<?xml version="1.0" encoding="UTF-8"?>
<p>Common respiratory virus infections have been studied chiefly in patients receiving high-dose chemotherapy and haematopoietic stem cell transplantation (HSCT). Compared with immunocompetent patients, several distinctive features have been reported. Viral shedding lasts longer and progression to pneumonia is more common [
 <xref ref-type="bibr" rid="CR31_21">31</xref>]. Late airflow obstruction has been reported in HSCT recipients [
 <xref ref-type="bibr" rid="CR40_21">40</xref>]. Some respiratory viruses are responsible for extra-respiratory manifestations. Although rare in immunocompetent hosts, these manifestations might be more common in patients with HM.
</p>
